Clinical evolution, CD4+ cell count, HIV, and HHV-8 viral load for each visit in a patient from the experimental group, with pulmonary KS diagnosed at baseline; he never developed Severe-IRIS-KS and had an uneventful evolution, with 70% remission at week 48.
(TIF)Click here for additional data file.